Key facts
- Arrellio’s last known valuation is $15.5M (Aug 2025).
- It has raised $6.1M across 1 recorded rounds; the latest was Seed Round ($3.5M) in Jul 2025.
- Notable investors include M25, Rex Salisbury.
- Arrellio has filed 1 Form D with the SEC, most recently Aug 2025 ($3.5M sold to 17 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Arrellio
Funding rounds
1 roundsAbout Arrellio
Operator of an order automation platform intended to improve operational efficiencies. The company's platform offers order automation, status communication, and price quotes among other features, enabling optometry professionals to deliver better patient care by removing administrative burdens.
- Sector
- Healthcare
- HQ
- Columbus, OH, United States
- Founded
- 2022
- Employees
- 11
- Website
- arrellio.com/
- Ownership
- Privately Held (backing)
Arrellio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arrellio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arrellio in its N-PORT filings yet. We sweep new filings monthly.